During the past decade, Groupe d'Etude des Lymphomes de l'adulte conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Groupe d'Etude des Lymphomes de l'adulte" #1 collaborator was "Amgen" with 2 trials as a collaborator, "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator, "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator, "HOVON - Dutch Haemato-Oncology Association" with 1 trials as a collaborator and "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Groupe d'Etude des Lymphomes de l'adulte" are "Diffuse Large Cell Lymphoma" (3 trials), "Follicular Lymphoma" (2 trials), "B-Cell Lymphoma" (1 trials) and "Lymphoma" (1 trials). Many other conditions were trialed in "Groupe d'Etude des Lymphomes de l'adulte" in a lesser frequency.

Most popular intervention types in "Groupe d'Etude des Lymphomes de l'adulte" are "Drug" (7 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "rituximab" (3 trials), "Bortezomib" (1 trials), "Darbepoetin alfa" (1 trials), "Rituximab" (1 trials) and "Zevalin plus BEAM" (1 trials). Other intervention names were less common.

The vast majority of trials in "Groupe d'Etude des Lymphomes de l'adulte" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Groupe d'Etude des Lymphomes de l'adulte". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Groupe d'Etude des Lymphomes de l'adulte, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Groupe d'Etude des Lymphomes de l'adulte, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".